Kisspeptin-10: Reproductive Neuroendocrine Research Compound

What Is Kisspeptin-10?

Kisspeptin-10 (KP-10) is the shortest biologically active fragment of the kisspeptin family of neuropeptides, consisting of 10 amino acids with the sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂. The C-terminal amidation is essential for receptor binding activity. Derived from the KISS1 gene product (kisspeptin-54), KP-10 retains full receptor affinity while offering improved pharmacological tractability compared to longer isoforms.

First characterized in the early 2000s as the endogenous ligand for GPR54 (now designated KISS1R), kisspeptin-10 has emerged as one of the most important peptide regulators of the hypothalamic-pituitary-gonadal (HPG) axis. It functions as a critical upstream gatekeeper of reproductive function, controlling gonadotropin-releasing hormone (GnRH) pulsatility and, consequently, the entire downstream reproductive hormone cascade.

The KISS1 gene was originally identified as a tumor suppressor (hence the "KiSS" nomenclature, from "Krüppel-Interacting Suppressor Sequences"), before its profound role in reproductive endocrinology was recognized. This dual identity as both a putative tumor suppressor and master reproductive regulator has made kisspeptin-10 a uniquely versatile research compound.

Mechanism of Action

KISS1R (GPR54) Receptor Binding

Kisspeptin-10 exerts its effects through high-affinity binding to the KISS1R receptor, a Gq/11 protein-coupled receptor expressed prominently in:

• •Hypothalamus: GnRH neurons (primary site for reproductive regulation)
• •Pituitary: Gonadotroph cells
• •Gonads: Testes and ovaries
• •Placenta: Particularly during pregnancy
• •Various brain regions: Amygdala, hippocampus, brainstem

The binding affinity of KP-10 for KISS1R (Ki approximately 1-2 nM) is comparable to longer kisspeptin isoforms, making it the preferred tool compound in receptor binding studies.

Intracellular Signaling Cascade

Upon KISS1R activation, KP-10 triggers a characteristic Gq/11-mediated signaling sequence:

1. Phospholipase C activation: Hydrolyzes PIP₂ into IP₃ and DAG

2. IP₃-mediated calcium release: Triggers intracellular calcium mobilization from ER stores

3. PKC activation: DAG activates protein kinase C isoforms

4. MAPK/ERK pathway: Downstream activation of proliferative and transcriptional regulators

5. Depolarization: In GnRH neurons, calcium influx triggers action potentials and GnRH release

This signaling cascade is rapid (seconds to minutes) and results in pulsatile GnRH secretion that drives downstream LH and FSH release.

Regulation of GnRH Pulsatility

The most critical function of kisspeptin-10 is its role in controlling GnRH pulsatility from hypothalamic neurons. GnRH is released in pulses, and the frequency and amplitude of these pulses determine the pattern of gonadotropin secretion:

• •High frequency, low amplitude GnRH pulses → Preferential LH secretion → Androgens
• •Low frequency, high amplitude GnRH pulses → Preferential FSH secretion → Follicular development

Kisspeptin neurons in the arcuate nucleus (ARC) form the GnRH pulse generator. These neurons co-express kisspeptin, NKB (neurokinin B), and dynorphin — the so-called "KNDy" neurons — and communicate through autocrine/paracrine loops that establish synchronized pulsatile kisspeptin release.

Sexual Dimorphism and Hormonal Feedback

Kisspeptin neurons respond to sex steroid feedback differently by sex and location:

Arcuate nucleus (ARC) kisspeptin neurons:

• •Subject to negative feedback from both estrogen and testosterone
• •Serve as the primary pulse generator
• •Critical for maintaining tonic gonadotropin secretion

Anteroventral periventricular nucleus (AVPV) kisspeptin neurons (sexually dimorphic, prominent in females):

• •Subject to positive estrogen feedback
• •Generate the preovulatory LH surge in cycling females
• •Largely absent in male rodents

This anatomical and functional dimorphism explains many sex differences in reproductive physiology and creates distinct research questions for male versus female reproductive endocrinology.

KISS1 as Tumor Suppressor

Beyond reproduction, KISS1 was originally identified for its ability to suppress tumor metastasis. KP-10 research in oncology has revealed:

• •Suppression of matrix metalloproteinase (MMP) expression, reducing ECM degradation
• •Inhibition of cell migration through downstream signaling affecting cytoskeletal dynamics
• •Induction of apoptosis in certain cancer cell lines through MAPK pathway modulation
• •Potential involvement in cancer stem cell regulation

The loss of KISS1/KISS1R expression correlates with increased metastatic potential in breast, thyroid, gastric, and ovarian cancers, positioning kisspeptin signaling as a potential therapeutic target.

Published Research

Reproductive Neuroendocrinology Studies

GnRH Pulse Regulation

Seminal work established that KP-10 infusion produces dose-dependent LH and FSH release in healthy volunteers through GnRH-dependent mechanisms. Blockade of GnRH receptors abolishes the gonadotropin response, confirming that kisspeptin acts upstream of the GnRH pulse generator ([Dhillo et al., J Clin Endocrinol Metab 2005]()).

Continuous kisspeptin-10 infusion paradoxically desensitizes the HPG axis, while pulsatile administration maintains gonadotropin responsiveness. This critical pharmacological distinction has shaped all subsequent research and clinical applications.

Hypogonadotropic Hypogonadism

Studies in patients with hypogonadotropic hypogonadism (HH) and Kallmann syndrome have demonstrated:

• •Preserved LH response to exogenous kisspeptin, confirming intact GnRH/pituitary axis below the level of kisspeptin deficiency
• •Potential to restore pulsatile LH secretion through intermittent kisspeptin administration
• •Identification of KISS1R mutations as a cause of congenital HH in several kindreds

Puberty Onset

The kisspeptin system serves as a central trigger for puberty initiation:

• •Kisspeptin mRNA expression increases dramatically in the hypothalamus during the pubertal transition
• •Earlier puberty is associated with increased kisspeptin neuron activation
• •Nutritional status modulates kisspeptin expression, providing a potential link between metabolic state and reproductive timing
• •Leptin-kisspeptin interaction mediates the "permissive" effect of adequate body fat for puberty onset

Polycystic Ovary Syndrome (PCOS) Research

PCOS, characterized by oligo-anovulation, hyperandrogenism, and polycystic ovarian morphology, is associated with dysregulated kisspeptin signaling:

• •Women with PCOS show elevated kisspeptin levels and altered GnRH pulse frequency
• •Excess androgens appear to compromise the negative feedback regulation of ARC kisspeptin neurons
• •Research exploring kisspeptin-targeted interventions to normalize GnRH pulsatility in PCOS is ongoing
• •Animal models of PCOS replicate kisspeptin dysregulation, providing translational research tools

Key reference: Skorupskaite et al. demonstrated that antagonism of kisspeptin signaling reduces LH pulse frequency in women with PCOS, confirming the pathological contribution of excess kisspeptin drive to the condition ([Hum Reprod 2020]()).

Male Reproductive Research

In males, kisspeptin-10 research has explored:

Testosterone Regulation

• •Intravenous KP-10 produces rapid, GnRH-dependent testosterone elevation in healthy men
• •Chronic pulsatile kisspeptin administration (2-hour pulses) maintains testosterone levels in men with functional hypothalamic hypogonadism
• •Age-related decline in kisspeptin sensitivity may contribute to late-onset hypogonadism

Male Fertility Research

• •Kisspeptin receptor mutations cause azoospermia through LH/FSH deficiency-mediated Sertoli and Leydig cell dysfunction
• •Kisspeptin neurons respond to testosterone via androgen receptors, establishing the negative feedback loop controlling male GnRH pulsatility
• •Seasonal changes in reproductive function in photoperiod-sensitive mammals are mediated through melatonin's effects on kisspeptin neuron activity

Oncology Research

Breast Cancer Metastasis

KISS1 expression inversely correlates with metastatic potential in breast cancer:

• •Loss of KISS1 expression is observed in ~60% of metastatic breast cancers compared to primary tumors
• •Re-expression of KISS1R in metastatic cell lines reduces invasiveness in vitro
• •In vivo studies show kisspeptin-overexpressing tumor cells form significantly fewer metastases in xenograft models

Other Malignancies

• •Gastric cancer: KISS1 silencing through promoter methylation correlates with lymph node metastasis
• •Thyroid cancer: Inverse correlation between KISS1R expression and tumor invasiveness
• •Pancreatic cancer: KP-10 demonstrates anti-migratory effects in pancreatic cancer cell lines

Research Specifications

• •Molecular weight: 1302.5 Da
• •Sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ (amidated C-terminus)
• •Formula: C₆₃H₈₃N₁₅O₁₃
• •CAS Number: 349438-38-6
• •Receptor affinity: Ki ~1-2 nM (KISS1R)
• •Plasma half-life: ~10 minutes (IV); ~30-45 minutes (SC)
• •Available forms: Lyophilized powder
• •Reconstitution solvent: Sterile water with 10% acetic acid (0.1% acetic acid solution)
• •Storage (lyophilized): -20°C
• •Storage (reconstituted): -80°C for extended storage; 4°C for short-term (≤1 week)
• •Target purity: ≥98% by HPLC
• •Classification: For laboratory research use only (RUO)

Practical Research Considerations

Reconstitution Protocol

Kisspeptin-10 presents reconstitution challenges due to its moderate hydrophobicity (attributable to Trp and Phe residues):

1. Initial solubilization: Add 10-20 μL of dilute acetic acid (0.1% in sterile water) per mg of peptide

2. Complete dissolution: Sonicate briefly (1-2 min) at low power if needed

3. Dilute to working concentration: Add phosphate-buffered saline or culture medium to target concentration

4. Avoid basic pH: KP-10 is poorly soluble above pH 8; maintain pH 6.5-7.4

5. Avoid BSA-free solutions: BSA (0.1%) prevents adsorption to polypropylene tubes at low concentrations

Pharmacological Considerations

Pulsatile vs. Continuous Administration

This distinction is critical in kisspeptin-10 research design:

Researchers designing in vivo protocols must account for tachyphylaxis with continuous infusion. Most protocols mimicking physiological function use intermittent delivery.

Metabolic Stability

KP-10 is rapidly degraded by circulating endopeptidases, limiting its utility for prolonged in vivo experiments. Research strategies to address this include:

• •D-amino acid substitutions at protease-vulnerable sites (particularly D-Tyr¹ or D-Trp³ analogs)
• •Kisspeptin analogs with extended half-life (e.g., MVT-602)
• •Pegylation to extend circulatory half-life
• •Micro-pump delivery systems for sustained in vivo administration

In Vitro Applications

KP-10 is widely used in cell-based research:

• •KISS1R calcium flux assays: Measures receptor activation via fluorescent calcium indicators (EC₅₀ ~1-5 nM)
• •cAMP assays: Monitors Gs pathway activation in KISS1R-transfected cell lines
• •β-arrestin recruitment assays: Investigates receptor desensitization and internalization
• •Migration assays: Measures anti-metastatic effects in cancer cell lines (typically 100 nM - 1 μM)

Safety Profile and Interactions

Adverse Effect Profile

Clinical studies using kisspeptin-10 as a research tool in human volunteers have reported an excellent short-term safety profile:

Injection studies (IV and SC):

• •Mild flushing in some subjects (likely related to rapid LH/testosterone surge)
• •Transient palpitations coinciding with hormonal peaks
• •No significant changes in blood pressure, heart rate, or ECG parameters
• •No hepatic or renal function alterations
• •No immune reactions or antibody formation reported

Prolonged infusion studies:

• •Hypogonadotropic effects with desensitization (expected pharmacological effect)
• •Reversible libido changes in males (associated with testosterone fluctuations)

Potential Drug Interactions

Pharmacodynamic interactions:

• •GnRH analogs: Competitive downstream effects on pituitary gonadotrophs
• •Sex steroids: Modulate kisspeptin neuron sensitivity and expression
• •Opioids: Dynorphin (co-expressed in KNDy neurons) inhibits kisspeptin release; opioid antagonism enhances kisspeptin-mediated LH secretion
• •Leptin: Permissive effect on kisspeptin neuron activity; leptin deficiency attenuates kisspeptin responsiveness

Comparison to Related Compounds

Kisspeptin-10 vs. Kisspeptin-54 (Metastin)

The longer isoform shares the same C-terminal decapeptide sequence as KP-10 but has different pharmacological properties:

KP-54 has been studied more extensively in clinical trials for anovulation due to better tolerability in clinical settings, but KP-10 remains the preferred tool compound for mechanistic research due to its smaller size and defined receptor pharmacology.

Kisspeptin-10 vs. GnRH

As the upstream regulator of GnRH, kisspeptin and GnRH have complementary but distinct research applications:

• •GnRH analogs (leuprolide, nafarelin) act directly at pituitary gonadotrophs, bypassing kisspeptin
• •Kisspeptin-10 acts at the hypothalamic level, offering a more physiological approach to reproductive axis manipulation
• •Kisspeptin resistance can occur when GnRH neurons are dysfunctional, distinguishing "kisspeptin-level" from "GnRH-level" defects in research models
• •Kisspeptin's combined hypothalamic-pituitary-gonadal targeting makes it a more integrative probe of HPG axis function

Kisspeptin-10 vs. Neurokinin B (NKB)

NKB is co-expressed with kisspeptin in KNDy neurons and modulates kisspeptin pulse generation:

• •NKB acts on KNDy neurons to trigger kisspeptin release (autocrine/paracrine)
• •The NKB-kisspeptin axis creates a self-amplifying pulse generator
• •NKB receptor antagonists reduce LH pulse frequency by suppressing kisspeptin
• •Combined research with kisspeptin and NKB is valuable for understanding pulse generator biology

Kisspeptin-10 in Metabolic Disease Research

Obesity and Reproductive Suppression

Metabolic dysfunction (obesity, undernutrition) commonly suppresses reproductive function through kisspeptin-mediated mechanisms:

• •Obesity: Elevated leptin in obese individuals paradoxically creates leptin resistance in kisspeptin neurons, contributing to PCOS-like reproductive phenotypes
• •Undernutrition: Reduced leptin and elevated cortisol suppress ARC kisspeptin expression, providing the "energy checkpoint" for reproduction
• •Type 2 diabetes: Insulin resistance impairs kisspeptin neuron function; kisspeptin levels are dysregulated in diabetic subjects

Stress-Reproductive Axis Cross-Talk

Psychological and physiological stress suppresses reproduction through:

• •Corticotropin-releasing hormone (CRH) direct inhibition of GnRH neurons
• •Glucocorticoid-mediated suppression of kisspeptin gene expression
• •Dynorphin release from KNDy neurons during stress responses

Understanding kisspeptin's role in this axis has implications for stress-induced reproductive disorders.

Future Research Directions

Therapeutic Development

Kisspeptin-10 research is informing several clinical development programs:

Anovulation and Fertility

• •Clinical trials using kisspeptin to trigger oocyte maturation in IVF (as alternative to hCG trigger)
• •Results show comparable oocyte yields with potentially reduced OHSS risk
• •Phase II data support development as a gentler, more physiological trigger for assisted reproduction

Male Hypogonadism

• •Pulsatile kisspeptin infusion as a potential treatment for hypogonadotropic hypogonadism
• •Advantage over GnRH therapy: upstream action preserves more physiological pulsatility

Cancer Therapeutics

• •KISS1R agonists as potential anti-metastatic agents
• •Early research in breast and gastric cancer models shows promise
• •Challenge: systemic reproductive effects complicate cancer-specific targeting

Analogs and Optimization

Research is actively developing kisspeptin analogs with improved properties:

• •MVT-602: A kisspeptin-10 analog with extended half-life (amino acid modifications improve metabolic stability)
• •Compound 15: High-affinity KP-10 analog used in receptor characterization
• •Peptide bond modifications: Reduced-amide and retro-inverso analogs with enhanced protease resistance

Internal Research Tools

Peptides.SO offers tools to support kisspeptin research:

• •Peptide Calculator: Determine reconstitution parameters and concentration conversions for kisspeptin-10
• •Stack Builder: Plan multi-peptide research protocols exploring reproductive endocrinology

Related research compounds:

• •Sermorelin — GHRH analog for pituitary function research
• •CJC-1295 DAC — sustained GHRH analog for GH axis research
• •Tesamorelin — metabolic GHRH research compound

Important Research Disclaimer

Kisspeptin-10 is classified as a research-use-only compound. The information in this article is intended for scientific educational purposes only and does not constitute medical advice. Kisspeptin-10 modulates reproductive hormones and should only be studied in properly controlled research settings with appropriate ethical oversight. Researchers should review applicable regulatory requirements before initiating studies with reproductive peptides.

For research purposes only. Not for human use outside of approved clinical studies and authorized research protocols.

Kisspeptin-10 Supplier Pricing Comparison (Live Data — 2026)

Kisspeptin-10 has a broad supplier market given its use in reproductive neuroendocrinology and fertility research. Peptides.SO tracks 75+ active listings across suppliers.

Price range: $0.05–$275/mg across 75 tracked suppliers. Most research-grade offerings fall in the $4–$50/mg range.

> Research Use Only. All material is sold strictly for laboratory research purposes. Not for human or animal administration.

See the Kisspeptin-10 peptide page for real-time pricing, CoA availability, and current stock status.

Frequently Asked Questions

What is the difference between Kisspeptin-10 and full-length Kisspeptin-54?

Kisspeptin-54 (also called metastin) is the primary circulating form of kisspeptin, produced by cleavage of the KISS1 gene product. Kisspeptin-10 is a C-terminal decapeptide fragment (residues 45-54 of Kisspeptin-54) that retains full receptor (KISS1R/GPR54) binding activity. The 10-amino acid fragment is commonly used in research because of its defined size, commercial availability, and confirmed biological activity in GnRH neuron activation assays. Both forms potently activate KISS1R, but Kisspeptin-54 has a longer half-life in vivo.

How does Kisspeptin-10 trigger GnRH release?

Kisspeptin-10 binds KISS1R (GPR54) on GnRH neurons in the hypothalamic preoptic area and arcuate nucleus. KISS1R couples to Gαq/11 proteins, activating phospholipase C and generating IP3/DAG — leading to intracellular calcium release and membrane depolarization. This depolarization triggers action potential firing in GnRH neurons, causing burst release of GnRH into the hypothalamic-portal circulation. GnRH then stimulates LH and FSH release from the anterior pituitary, completing the neuroendocrine cascade that drives gonadal function.

What is the KNDy neuron concept and why is it important in Kisspeptin research?

KNDy neurons are a specific population of arcuate nucleus neurons that co-express Kisspeptin, Neurokinin B (NKB), and Dynorphin. These neurons are believed to be the primary GnRH pulse generator — responsible for the pulsatile LH secretion essential for normal reproductive function. NKB (acting via NK3R) excites KNDy neurons and propagates kisspeptin release; dynorphin provides inhibitory feedback to terminate each pulse. Kisspeptin-10 research often focuses on KNDy neurons as the cellular substrate for understanding LH pulse frequency, reproductive cycling, and how metabolic or stress signals regulate fertility.

How does stress affect kisspeptin signaling?

Stress hormones — particularly cortisol/corticosterone via hypothalamic GR — suppress NPVF (encoding RFamide-related peptides) and can directly inhibit KNDy/kisspeptin neuron firing. Elevated CRF (corticotropin-releasing factor) acts on CRFR1 receptors on kisspeptin neurons to reduce GnRH pulse frequency. This is one of the well-studied mechanisms underlying stress-induced reproductive suppression (hypothalamic amenorrhea in women, reduced testosterone in chronically stressed males). Research models using Kisspeptin-10 have been instrumental in mapping this stress-reproductive axis.

What role does kisspeptin play in puberty onset?

The foundational Seminara et al. 2003 N Engl J Med paper established GPR54 (KISS1R) mutations as a cause of hypogonadotropic hypogonadism with failure of puberty onset. This proved that kisspeptin/KISS1R signaling is required for pubertal GnRH pulse activation in humans. Research since has documented that the hypothalamic kisspeptin system is quiescent in prepubertal animals and activated at puberty — correlating with rising sex steroids that feed back positively to enhance kisspeptin drive. Kisspeptin-10 research models are used to probe the neuroendocrine gating of puberty.

How is Kisspeptin-10 used in fertility research models?

Kisspeptin-10 administration in research models reliably induces LH pulses in a dose-dependent fashion, making it a precise tool for studying GnRH/LH pulse dynamics. Research applications include: characterizing KISS1R signaling pharmacology, mapping kisspeptin-responsive GnRH neuron populations, studying feedback mechanisms (estrogen negative/positive feedback through kisspeptin neurons), investigating hypothalamic control of seasonal reproduction (photoperiod-melatonin-kisspeptin axis in seasonal breeders), and testing kisspeptin analogs as potential fertility modulators.

Key Research Citations

1. Seminara SB, et al. (2003). The GPR54 gene as a regulator of puberty. N Engl J Med, 349(17):1614-1627. PMID: 14573733

2. Pinilla L, et al. (2012). Kisspeptin and the hypothalamic control of reproduction: lessons from the human. Endocrinology, 153(11):5167-5177. PMID: 23015291

3. Roa J, et al. (2008). Kisspeptin and KISS1R: a critical pathway in the reproductive system. Reproduction, 136(3):295-301. PMID: 18515314

4. Gottsch ML, et al. (2025). Kisspeptin control of hypothalamus-pituitary-ovarian functions. Vitam Horm, 126:125-171. PMID: 39864941

---

Further Reading:

• •Gonadorelin (GnRH): The Master Reproductive Decapeptide in Neuroendocrine and Oncology Research
• •Oxytocin: The Nonapeptide Redefining Neuroendocrine and Social Behavior Research
• •Triptorelin (D-Trp6-GnRH): Complete Research Profile — GnRH Superagonist for Oncology, Reproductive, and Neuroendocrine Research (2026)
• •PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide): The Pleiotropic Neuropeptide Driving Neuroscience and Stress Research
• •Reconstitution Calculator
• •Peptide Stack Builder

---

2026 Pricing & Supplier Comparison

Peptides.SO tracks 54+ active listings for Kisspeptin-10 as of August 2026. Kisspeptin-10 (the decapeptide fragment Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, also called metastin(45-54)) is less commoditized than compounds like BPC-157 or Selank, resulting in a narrower but still meaningful supplier pool.

Live Price Benchmarks (August 2026)

Live, updated pricing available at /peptide/kisspeptin-10.

Market range: $0.05/mg – $275/mg across 54+ tracked listings. The median market price for standard catalog quantities is approximately $4–5/mg.

COA Verification for Kisspeptin-10

Kisspeptin-10 (MW: 1302.5 Da as the free acid; 1301.5 Da amide form) can appear in multiple salt or amide forms. Key documentation checkpoints:

• •Molecular weight confirmation: Confirm whether you are receiving the free acid or C-terminal amide form (RF-NH2 terminus) — the amide form is typically the biologically active version matching endogenous Kisspeptin-10
• •HPLC purity: ≥98% recommended for receptor binding and cell-signaling studies
• •MS data: Should show the correct [M+H]+ or [M+2H]2+ ion within ±1 Da of expected
• •Reconstitution: Kisspeptin-10 has moderate solubility; 1% acetic acid or PBS (pH 7.4) typically gives the best results. See the solubility guide for protocols.

Internal Resources

• •Kisspeptin-10 Compound Page — live pricing across 54+ suppliers
• •Peptide Reconstitution Calculator — dosing and solubility tool
• •How to Read a Peptide COA — documentation evaluation
• •Peptide Purity Testing: HPLC and Mass Spectrometry — understanding test methods

---